Arcutis Biotherapeutics, Inc. <ARQT.O>: Morgan Stanley raises target price to $38.00 from $34.00
ARQT•Related News
Latham Group CEO, CFO to join Barclays Building & Building Products Conference Q&A session
SWIM•
NextTrip partners with KC Global Media to expand JOURNY TV across Asia-Pacific, Middle East and Africa
NTRP•
Zscaler schedules fiscal Q4 2026 earnings call
ZS•
MBX Biosciences Q2 FY26 net loss widens to $37.1 million; R&D expenses rise to $31 million
MBX•
Delcath Systems Q2 Revenue USD 29.133 Million Vs. IBES Estimate USD 26.3 Million
DCTH•